EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Metabolic Syndrome and Psoriasis: Pivotal Roles of Chronic Inflammation and Gut Microbiota

Paola Secchiero, Erika Rimondi iD, Annalisa Marcuzzi iD, Giovanna Longo iD, Chiara Papi iD, Marta Manfredini, Matteo Fields iD, Lorenzo Caruso iD, Roberta Di Caprio, Anna Balato

International Journal of Molecular Sciences · 25.07.2024 · 25 (15) · 8098

DOI: 10.3390/ijms25158098 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.07.2024. Verfasst von Paola Secchiero und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine and LTTA Centre, University of Ferrara, 44121 Ferrara, Italy. Hauptthemen laut MEDLINE: Psoriasis, Metabolic Syndrome, Gastrointestinal Microbiome, Inflammation. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: uropean Union, Next Generation EU. "Finanziato dall'Unione europea - Next Generation EU - PNRR M6C2 - Investimento 2.1 Valorizzazione e potenziamento della ric…, European Union, Next Generation EU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, the incidence of metabolic syndrome (MS) has increased due to lifestyle-related factors in developed countries. MS represents a group of conditions that increase the risk of diabetes, cardiovascular diseases, and other severe health problems. Low-grade chronic inflammation is now considered one of the key aspects of MS and could be defined as a new cardiovascular risk factor. Indeed, an increase in visceral adipose tissue, typical of obesity, contributes to the development of an inflammatory state, which, in turn, induces the production of several proinflammatory cytokines responsible for insulin resistance. Psoriasis is a chronic relapsing inflammatory skin disease and is characterized by the increased release of pro-inflammatory cytokines, which can contribute to different pathological conditions within the spectrum of MS. A link between metabolic disorders and Psoriasis has emerged from evidence indicating that weight loss obtained through healthy diets and exercise was able to improve the clinical course and therapeutic response of Psoriasis in patients with obesity or overweight patients and even prevent its occurrence. A key factor in this balance is the gut microbiota; it is an extremely dynamic system, and this makes its manipulation through diet possible via probiotic, prebiotic, and symbiotic compounds. Given this, the gut microbiota represents an additional therapeutic target that can improve metabolism in different clinical conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisMetabolic SyndromeGastrointestinal MicrobiomeInflammationHumansAnimalsObesity

Stichwörter der Autor:innen

adipose tissueinflammationinsulin resistancemetabolic syndromepsoriasis

Autor:innen und Institutionen

  • Department of Translational Medicine and LTTA Centre, University of Ferrara, 44121 Ferrara, Italy.
  • Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
  • Department of Environmental and Prevention Sciences, University of Ferrara, 44121 Ferrara, Italy.
  • Dermatology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli, 80131 Naples, Italy.

ORCID-Profile: Erika Rimondi, Annalisa Marcuzzi, Giovanna Longo, Chiara Papi, Matteo Fields, Lorenzo Caruso

Förderung

  • uropean Union, Next Generation EU. "Finanziato dall'Unione europea - Next Generation EU - PNRR M6C2 - Investimento 2.1 Valorizzazione e potenziamento della ric…
  • European Union, Next Generation EU

Zitieren

APA

Secchiero, P., Rimondi, E., Marcuzzi, A., Longo, G., Papi, C., Manfredini, M., Fields, M., Caruso, L., Di Caprio, R., & Balato, A. (2024). Metabolic Syndrome and Psoriasis: Pivotal Roles of Chronic Inflammation and Gut Microbiota. International Journal of Molecular Sciences, 25(15), 8098. https://doi.org/10.3390/ijms25158098

Vancouver

Secchiero P, Rimondi E, Marcuzzi A, Longo G, Papi C, Manfredini M, et al. Metabolic Syndrome and Psoriasis: Pivotal Roles of Chronic Inflammation and Gut Microbiota. International Journal of Molecular Sciences. 2024;25(15):8098. doi:10.3390/ijms25158098

BibTeX
@article{Secchiero2024,
  author = {Secchiero, Paola and Rimondi, Erika and Marcuzzi, Annalisa and Longo, Giovanna and Papi, Chiara and Manfredini, Marta and Fields, Matteo and Caruso, Lorenzo and Di Caprio, Roberta and Balato, Anna},
  title = {Metabolic Syndrome and Psoriasis: Pivotal Roles of Chronic Inflammation and Gut Microbiota},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {15},
  pages = {8098},
  doi = {10.3390/ijms25158098}
}
Kostenlos starten →